• Profile
Close

Analysis of readmissions following hospitalization for cellulitis in the United States

JAMA Dermatology Mar 03, 2019

Fisher JM, et al. - Via this nationally weighted, retrospective cohort analysis of US hospital admissions, researchers determined the national rate of readmission within 30 days of hospital discharge for cellulitis. They identified 447,080 index admissions with a primary diagnosis of cellulitis. Among these, 9.8% had nonelective readmission within 30 days. More than $500 million was reported for all-cause, nonelective readmissions after cellulitis discharge, and more than $100 million was noted for readmissions for skin and subcutaneous infections. These findings suggested that readmission after hospitalization for cellulitis were commonly encountered, which were costly. These readmissions could be prevented via improved diagnostics, therapeutics, and discharge care coordination.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay